Skip to main content
Overview
Company
Company Profile
Management
Our History
Science
Scientific Approach
Antibody Formats
Publications
Products
Pipeline Overview
Lacutamab
IPH4502
Monalizumab
Other Clinical Stage Assets
IPH6501
IPH6101
IPH6401
IPH5201
IPH5301
Partnering
Investors
Overview
News
Events
Stock Info
Share Information
Stock Quote & Chart
Analyst Coverage
Financials & Regulatory Information
Financial Reports
SEC Filings
Number of Shares and Voting Rights
Articles of Association
Share Repurchase Liquidity Agreement
Prospectus Related to Public Offering
Appraiser Reports
Regulated Agreements
General Shareholders' Meeting
Governance
Corporate Governance
Management Team
Email Alerts
Media
Media Hub
All Press Releases
Media Center
Careers
Skip to main content
Français
Event Details
Publication of revenue and cash position for 3Q2026
November 5, 2026
09:00 AM ET
Add to Calendar
Add to Apple Calendar
Add to Google Calendar
Add to Microsoft Outlook
Add to iCalendar
Remind me
24 Hours
3 Days
7 Days
Email:
Please provide an email address.
Please provide a valid email address.